TransCode Therapeutics, Inc. (RNAZ) Dividend Yield, History & Forecast
TransCode Therapeutics, Inc. (RNAZ) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Capital Market. market capitalization is approximately $8M.
Frequently Asked Questions about TransCode Therapeutics, Inc. (RNAZ)
Is TransCode Therapeutics, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is TransCode Therapeutics, Inc. in?▾
TransCode Therapeutics, Inc. (RNAZ) operates in the Healthcare sector, specifically the Biotechnology industry.
